project id: TCGA-BLCA; case submitter id: TCGA-KQ-A41O; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.77; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.25; rna integrity number: 8.0; age at index: 84; days to birth: -30774; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1927; age at diagnosis: 30774; ajcc clinical t: TX; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1538.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 800.0; sample id: 4d1b5d93-e1af-4c6b-b4f6-b327a6a82ae6; sample submitter id: TCGA-KQ-A41O-01A; portion id: 49504042-670a-4292-a0ca-bc3628a0637f; portion submitter id: TCGA-KQ-A41O-01A-12; slide id: 87725927-4bf3-4eab-bc4b-a16fe7680951; slide submitter id: TCGA-KQ-A41O-01A-01-TSA; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; section location: TOP;